Skip to Main Content

Paper Details

First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.
J Nucl Med
8
2023
., Cu, Human, MM, VLA4, [Cu], [Cu]Cu-CB-TE1A1P, biopsy, human, humans, inflammatory micro-environmental cells, integrin, malignant MM cells, mice, participant, participants, pathogenic, patients, red marrow, very late antigen-4
Author NameAffiliation
Ravi VijAlvin J. Siteman Cancer Center, Washington University School of Medicine
Ravi VijWashington University School of Medicine
John F DiPersioAlvin J. Siteman Cancer Center, Washington University School of Medicine
John F DiPersioWashington University School of Medicine
  • 1 - 4

Datasets

Release 1.2